Denali Therapeutics (DNLI) Interest Coverage Ratio Growth (1y) (2018 - 2026)
Denali Therapeutics (DNLI) Interest Coverage Ratio Growth (1y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.59% |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -76.72% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 85.51% |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 12.13% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 90.10% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | -48.36% |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1,170.12% |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 99.48% |
| 10 | Denali Therapeutics | 3.90 Bn | 3.90 Bn | 3.51 Mn | 6.50% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 6.50% |
| Mar 31, 2026 | -383.43% |
| Dec 31, 2025 | -2.42% |
| Sep 30, 2025 | -8.01% |
| Jun 30, 2025 | 93.13% |
| Mar 31, 2025 | -19.11% |
| Dec 31, 2024 | 5.18% |
| Sep 30, 2024 | -4.80% |
| Jun 30, 2024 | -166.21% |
| Mar 31, 2024 | -4.52% |
| Dec 31, 2023 | -34.99% |
| Sep 30, 2023 | -9.89% |
| Jun 30, 2023 | 368.85% |
| Mar 31, 2023 | -58.76% |
| Dec 31, 2022 | -19.41% |
| Sep 30, 2022 | -13.41% |
| Jun 30, 2022 | 4.84% |
| Mar 31, 2022 | 9.55% |
| Dec 31, 2021 | -130.58% |
| Sep 30, 2021 | -37.92% |